Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.61 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CLK2 | P49760 | 3/20 | 0.47 |
| ▸ | CLK3 | P49761 | 3/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.47 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.44 |
| ▸ | ABL1 | P00519 | 2/20 | 0.43 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | CHUK | O15111 | 1/20 | 0.41 |
| ▸ | VCP | P55072 | 1/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.37 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.37 |
| ▸ | WNT1 | P04628 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1463580 | 0.91 | CYP19A1 (0.53) | CYP11B1CYP11B2CYP19A1CLK2CLK3 | |
| SCHEMBL12745937 | 0.89 | CYP11B1 (0.56) | CYP11B1CYP11B2CYP19A1CLK2CLK3 | |
| SCHEMBL1461024 | 0.87 | CYP19A1 (0.54) | CYP11B1CYP11B2CYP19A1CDK5CDK5R1 | |
| SCHEMBL1460163 | 0.83 | CYP11B1 (0.51) | CYP11B1CYP11B2CYP19A1CLK2CLK3 | |
| SCHEMBL12826293 | 0.83 | CLK2 (0.49) | CYP11B1CYP11B2CLK2CLK3DYRK1A | |
| SCHEMBL1463753 | 0.82 | CYP11B1 (0.48) | CYP11B1CYP11B2CYP19A1CLK2CLK3 | |
| SCHEMBL1459224 | 0.82 | CYP19A1 (0.42) | CYP11B1CYP11B2CYP19A1CDK5CDK5R1 | |
| SCHEMBL1463139 | 0.81 | CYP19A1 (0.49) | CYP11B1CYP11B2CYP19A1CDK5CDK5R1 | |
| SCHEMBL1460198 | 0.81 | CYP19A1 (0.47) | CYP11B1CYP11B2CYP19A1CDK5CDK5R1 | |
| SCHEMBL1460303 | 0.81 | CYP19A1 (0.43) | CYP11B1CYP11B2CYP19A1CDK5CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102574788-A | Indole derivatives as crac modulators | HOFFMANN LA ROCHE | 2012-07-11 | — | — | CN | disclosed |
| US-20110071150-A1 | INDOLE DERIVATIVES AS CRAC MODULATORS | ALAM MUZAFFAR | 2011-03-24 | — | — | US | disclosed |
| US-20110071150-A1 | INDOLE DERIVATIVES AS CRAC MODULATORS | ALAM MUZAFFAR | 2011-03-24 | — | — | US | disclosed |
| US-20110071150-A1 | INDOLE DERIVATIVES AS CRAC MODULATORS | ALAM MUZAFFAR | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071150-A1 | INDOLE DERIVATIVES AS CRAC MODULATORS | ORAI1, RYR2, CACNA1E | CYP11B1 947/4885CYP11B2 977/4885CYP19A1 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.